Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne M Butler

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
Brachytherapy|August 9, 2011
Higher percentage of positive biopsy cores and Gleason score are associated with a greater degree of prostate gland shrinkage after neoadjuvant cytoreductive therapyNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapyAngela Niehaus, Gregory S Merrick, Wayne M Butler, et al.
Cancer Journal (Sudbury, Mass.)|May 4, 2007
Long-term rectal function after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Cancer|June 6, 2007
Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancerGregory S Merrick, Robert W Galbreath, Wayne M Butler, et al.
Brachytherapy|April 28, 2004
The effect of hormonal manipulation on urinary function following permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2007
Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beamGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancerAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Journal of Contemporary Brachytherapy|January 30, 2014
Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatmentAl V Taira, Gregory S Merrick, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics|March 27, 2010
Permanent prostate brachytherapy in prostate glands <20 cm(3)Jyoti Mayadev, Gregory S Merrick, Joshua R Reed, et al.
Urology|July 9, 2002
Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesityGregory S Merrick, Wayne M Butler, Kent Wallner, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Brachytherapy|August 9, 2011
Higher percentage of positive biopsy cores and Gleason score are associated with a greater degree of prostate gland shrinkage after neoadjuvant cytoreductive therapyNathan Bittner, Gregory S Merrick, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapyAngela Niehaus, Gregory S Merrick, Wayne M Butler, et al.
Cancer Journal (Sudbury, Mass.)|May 4, 2007
Long-term rectal function after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Cancer|June 6, 2007
Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancerGregory S Merrick, Robert W Galbreath, Wayne M Butler, et al.
Brachytherapy|April 28, 2004
The effect of hormonal manipulation on urinary function following permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2007
Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beamGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancerAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Journal of Contemporary Brachytherapy|January 30, 2014
Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatmentAl V Taira, Gregory S Merrick, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics|March 27, 2010
Permanent prostate brachytherapy in prostate glands <20 cm(3)Jyoti Mayadev, Gregory S Merrick, Joshua R Reed, et al.
Urology|July 9, 2002
Permanent prostate brachytherapy-induced morbidity in patients with grade II and III obesityGregory S Merrick, Wayne M Butler, Kent Wallner, et al.
Pageof 17